Boothbay Fund Management’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-14,481
Closed -$359K 2537
2025
Q4
$359K Sell
14,481
-2,583
-15% -$68.6K 0.01% 1330
2025
Q3
$484K Buy
+17,064
New +$462K 0.01% 1189
2020
Q1
Sell
-11,305
Closed -$208K 1102
2019
Q4
$208K Buy
+11,305
New +$188K 0.02% 702

Other funds holding ASTH

Boothbay Fund Management's ASTH Position: Q1 2026 in Review

Boothbay Fund Management sold out of Astrana Health (ASTH) in Q1 2026, closing a stake of 14,481 shares — an estimated $359K sold.

Boothbay Fund Management first reported a position in ASTH in Q4 2019 and held it in 3 quarters. The position peaked at $484K in Q3 2025. 171 funds tracked by Wall St. Rank hold ASTH as of Q1 2026.

  • Boothbay Fund Management reported no remaining Astrana Health position as of Q1 2026 after selling out during the quarter.
  • Boothbay Fund Management sold 14,481 Astrana Health shares in Q1 2026, an estimated $359K.
  • Boothbay Fund Management first reported a position in Astrana Health in Q4 2019 and held it in 3 quarters.
  • Boothbay Fund Management's Astrana Health position peaked at $484K in Q3 2025.
  • 171 funds tracked by Wall St. Rank held Astrana Health as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.